We still have 2-5 months for the clinical trial updates for VAXINIA and OASIS so the $20M CN is still at 125% of 3.8c right now and you posted that before the excellent clinical trial update for Azer-Cel so you've placed no valuation for Azer-Cel?? DLBCL might be a small market but the treatment cost are currently very expensive which is expected for rare cancer.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.3¢ |
Change
-0.001(3.85%) |
Mkt cap ! $93.33M | |||
| Open | High | Low | Value | Volume |
| 1.2¢ | 1.3¢ | 1.2¢ | $105.8K | 8.703M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 58 | 10869437 | 1.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.3¢ | 12492048 | 36 |
View Market Depth
| Last trade - 15.14pm 24/06/2025 (20 minute delay) ? |
| IMU (ASX) Chart |